EZH2 and meningioma: Although not seen in our CNS WHO grade 3 meningioma cohort, the association of H3 K27me3 loss and poor prognosis in meningiomas of lower grades appears to contradict the inhibitory effect of EZH2 inhibition on IOMM-Lee tumor cell proliferation.